National Bioeconomy Blueprint

On April 26, 2012, the Obama Administration announced its commitment to strengthening bioscience research as a major driver of American innovation and economic growth. OSTP is pleased to release the National Bioeconomy Blueprint:

For background, on September 16, 2011, President Obama announced the development of a National Bioeconomy Blueprint detailing Administration-wide steps to harness biological research innovations to address national challenges in health, food, energy, and the environment.

In October 2011, the White House Office of Science and Technology Policy issued a Request for Information (RFI) soliciting public comment on ideas and priorities for building the U.S. bioeconomy to inform the development of a National Bioeconomy Blueprint.

National Bioeconomy Blueprint: Public Comment

OSTP sought comment in the following areas:

Grand challenges: President Obama has identified ‘‘grand challenges’’ as an important element of his innovation strategy, such as ‘‘smart anti-cancer therapeutics that kill cancer cells and leave their normal neighbors untouched; early detection of dozens of diseases from a saliva sample; personalized medicine that enables the prescription of the right dose of the right drug for the right person; a universal vaccine for influenza that will protect against all future strains; and regenerative medicine that can end the agonizing wait for an organ transplant.’’

Research and development: R&D investments, particularly in platform technologies, can support advances in health, energy, the environment, and agriculture, and accelerate the pace of discovery in fundamental life sciences research.

Moving life sciences breakthroughs from lab to market: It is a challenge to commercialize advances in the life sciences because of the risk, expense, and need for many years of sustained investment. The Administration is interested in steps that it can take directly, but is also interested in encouraging experimentation with new private-sector-led models for funding commercialization of life sciences research.

Workforce development: Investment in education and training is essential to creating a technically-skilled 21st century American bioeconomy workforce.

Reducing regulatory barriers to the bioeconomy: As President Obama has stated, our regulatory system must ‘‘identify and use the best, most innovative, and least burdensome tools for achieving regulatory ends’’ and ‘‘protect public health, welfare, safety, and our environment while promoting economic growth, innovation, competitiveness, and job creation.’’

Public-private partnerships: The Administration is interested in serving as a catalyst for public-private partnerships that build the bioeconomy and address important unmet needs in areas such as health, energy, agriculture, and environment.

This page provides an overview of the RFI and access to the 135 responses. The comments are presented chronologically below.  Clicking on an index number will open a PDF of the comment.  Additional materials provided by commenters are presented in the Supplementary Information column. A single PDF with all comments, and another with all supplementary information, are provided at the bottom of the page.

Index # Name Institution Supplementary Information
1 Robert Carlson Biodesic 1a
2 Saleem H. Ali, PhD University of Vermont 2a
3 Phillip A. Sharp    
4 Kory R. Johnson    
5 David Johnson, PhD GigaGen, Inc.  
6 Dennis F. Miller Solena Group, Inc. 6a
7 Arlen Meyers Society of Physician Entrepreneurs  
8 Franco Vitaliano (1)  ExQor Technologies 8a
9 Dale VanderPutten, MBA, PhD Omnia Biologics, Inc.  
10 Leslie Glick    
11 Alice Rathjen    
12 Franco Vitaliano (2)  ExQor Technologies 12a
13 Robert T. Nuner    
14 Ron Grow    
15 Mike Summer    
16 Lani O'Flynn Pure Lignin Environmental Technology Ltd. 16a
17 Sandra Brinckerhoff    
18 Burt Brinckerhoff    
19 Percival Zhang (1) Virginia Tech  
20 Percival Zhang (2) Virginia Tech  
21 Jonathan Taub    
22 (anonymous)    
23 Franco Vitaliano (3)  ExQor Technologies 23a
24 Paul T Smith, Jr. Flatley Discovery Lab  
25   New Jersey Community College Consortium for Workforce & Economic Development  
26 Melinda Duncan, PhD Department of Biological Sciences, University of Delaware  
27 Clark Miller Consortium for Science, Policy & Outcomes, Arizona State University  
28 Michael Lerman, PhD    
29 Franco Vitaliano (4) ExQor Technologies 29a
30 Chris Pickett    
31 John Perchorowicz, PhD Triage Masters LLC  
32 Elaine A. Cohen Hubal, PhD US EPA  
33 Regis Kelly, PhD California Institute for Quantitative Biosciences, UCSF  
34 Anthony C. Ostrowski, PhD Oceanic Institute  
35 Frank Cipriani BioFarms Hawaii LLC  
36 Frank Douglas, MD,  PhD, on behalf of Austen BioInnovation Institute in Akron  
37 Lily Chen, PhD San Francisco State University  
38 Elizabeth Woeckner, M.A., on behalf of Citizens for Responsible Care and Research  
39 Sandra Porter, PhD Bio-Link   
40 Richard O. Snyder, PhD, on behalf of Department of Molecular Genetics and Microbiology, University of Florida  
41 Mary Woolley on behalf of Research!America  
42 Michael P. Vitek, PhD (1) on behalf of Cognosci, Inc.  
43 Michael P. Vitek, PhD (2) on behalf of Cognosci, Inc.  
44 Barry Bochner, PhD Biolog, Inc.  
45 Frances Toneguzzo    
46 Elaine A. Johnson, PhD, on behalf of Bio-Link National Center  
47 Franco Vitaliano (5)  ExQor Technologies, Inc. 47a
48   Council of Graduate Schools  
49 Michael C. Jewett Department of Chemical and Biological Engineering, Northwestern U  
50   Advisory Committee for Biotechnology in the Piedmont Triad  
51 Chris Weeks, PhD Michigan State University  
52 Joseph C. LaManna on behalf of FASEB  
53 Philip Gibson, PhD Gwinnett Technical College  
54   American Society for Cell Biology  
55   University of Houston  
56 Mark Riley, PhD Agricultural and Biosystems Engineering, The University of Arizona  
57 Barbara Wanvig    
58 James W. Oltjen, Ph.D., on behalf of Federation of Animal Science Societies  
59   National Agricultural Biotechnology Council  
60 Bill Holmberg/Taylor Marshall on behalf of  Biomass Coordinating Council/American Council On Renewable Energy  
61 Ann Bonham, PhD on behalf of Association of American Medical Colleges  
62 Daniel Perry on behalf of Alliance for Aging Research  
63 Joey P. Granger, PhD on behalf of American Physiological Society  
64   Society for Neuroscience  
65 Teri Willey Mount Sinai Medical Center  
66 Phyllis B. Siegel on behalf of Biomedical Development Corporation  
67 Robin L .Rasor, M.S., CLP, RRTP, on behalf of Association of University Technology Managers  
68 Rose Maria Li, MBA, PhD Rose Li and Associates, Inc.  
69 Clyde Briant on behalf of Brown University  
70 Alan Kemper/Marc Curtis on behalf of American Soybean Association/United Soybean Board  
71 W. Steven Burke on behalf of Biofuels Center of North Carolina  
72 Claude Canizares on behalf of MIT  
73 Bruce Stillman, PhD, FRS Cold Spring Harbor Laboratory  
74 Alan S. Rudolph, PhD, MBA    
75 Andreas Heltzel, PhD, et al. on behalf of Biotechnology Department, Athens Technical College  
76   Small Biotechnology Business Coalition  
77 R. Thomas Van Arsdall on behalf of National Coalition for Food and Agricultural Research  
78   Onyx Pharmaceuticals  
79   American Society of Plant Biologists (ASPB)  
80 Dr. Charles Hamner/George Patterson/Leslie Platt/Timothy Stephens    
81   Society for Industrial and Applied Mathematics  
82 Janet Trunzo on behalf of Advanced Medical Technology Association 82a
83 Stephen S. Tang, PhD, MBA on behalf of University City Science Center  
84 Wenonah Hauter on behalf of Food & Water Watch  
85   American Society for Biochemistry and Molecular Biology  
86 Raymond L. Woosley, MD, PhD on behalf of Critical Path Institute  
87 James C. Greenwood on behalf of Biotechnology Industry Organization 87a
88 Bev Perdue, Governor /A. Blanton Godfrey on behalf of State of North Carolina/North Carolina Board of Science and Technology  
89 Nancy M. Hood on behalf of ArborGen Inc.  
90   Tufts University  
91 Kevin Whaley / Bethany Young Holt on behalf of Coalition Advancing Multipurpose Prevention Technologies / Initiative for Multipurpose Prevention Technologies  
92 Aprile L. Pilon, PhD Clarassance, Inc.  
93 Randall J. Legeai on behalf of Tulane University  
94   Association of Independent Research Institutes  
95 Cathee Johnson Phillips, MA on behalf of National Postdoctoral Association  
96 Sally Kenyon Grant on behalf of Maryland Department of Business & Economic Development  
97 Stephen L. Ferguson on behalf of Cook Group, Inc.  
98 David Hooper/Roberto Kolter/Bonnie Bassler on behalf of American Society for Microbiology  
99 Richard I. Smith on behalf of Pharmaceutical Research and Manufacturers of America  
100   Codexis, Inc.  
101 Christopher R. Braden, MD on behalf of Division of Foodborne, Waterborne and Environmental Diseases, CDC  
102 Randolph Hall on behalf of University of Southern California  
103 Eric Landis    
104 Dr. Stephen E. Cross / Dr. Harold Shlevin on behalf of Advanced Technology Development Center-Biosciences, Georgia Tech  
105 Larry Schookon behalf of University of Illinois  
106   Novozymes North America Inc.  
107 L. Val Giddings, PhD on behalf of The Information Technology and Innovation Foundation  
108   National Corn Growers Association  
109 Dr. Frank Ferrone on behalf of Department of Physics, Drexel University  
110 Mark P. Stevenson on behalf of LifeTechnologies  
111 Robert Friedman, PhD/Sarah R. Carter, PhD/Michael Rodemeyer, J.D. on behalf of J. Craig Venter Institute  
112   Association of American Universities  
113   American Society of Clinical Oncology  
114 Margaret Anderson on behalf of FasterCures  
115 David Guston/Clark Miller/J. Benjamin Hurlbut, PhD Consortium for Science, Policy & Outcomes/School of Life Sciences Arizona State University  
116 Jason Kelly on behalf of Gingko Bioworks  
117   DuPont  
118 Eugenia Jones, PhD Gist Consulting LLC  
119 Jennie Hunter Cevera, PhD on behalf of RTI International  
120 Chris Melancon/Daniel J. Mazella on behalf of Spyglass Biosecurity / Farragut Advisory Services LLC  
121 Robert Carlson Biodesic 121a
122 Jon Kuniholm Open Prosthetics Project  
123 John Cumbers BioSysBio  
124   New Mexico State University  
125 Megan J. Palmer, PhD Department of Bioengineering, Stanford University  
126 Heidi Imker, PhD on behalf of Enzyme Function Initiative  
127 Martina Newell-McGloughlin NSF / CREATE / IGERT  
128 Mike Beebe, Governor/Mary L. Good on behalf of State of Arkansas/University of Arkansas at Little Rock Center for Excellence in Regulatory Science  
129 Ellen Bergfeld on behalf of American Society of Agronomy/Crop Science Society of America/Soil Science Society of America  
130 W. Ron DeHaven, DVM, MBA/Bennie Osburn, DVM, PhD, DACVP on behalf of American Veterinary Medical Association/Association of Veterinary Medical Colleges  
131 Robin L. Rasor, M.S., CLP, RRTP on behalf of (2) Association of University Technology Managers  
132 James R. Gorman, MD, PhD Healthcare Innovation Laboratory  
133 Dietrich Hauffe, PhD on behalf of QIAGEN  
134   Department of Nanoscience, University of North Carolina-Greensboro  
135 Barbara P. Glenn, PhD on behalf of CropLife America